Type |
Details |
Score |
Publication |
First Author: |
Chu KL |
Year: |
2020 |
Journal: |
J Leukoc Biol |
Title: |
GITR differentially affects lung effector T cell subpopulations during influenza virus infection. |
Volume: |
107 |
Issue: |
6 |
Pages: |
953-970 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zaid A |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
Chemokine Receptor-Dependent Control of Skin Tissue-Resident Memory T Cell Formation. |
Volume: |
199 |
Issue: |
7 |
Pages: |
2451-2459 |
|
•
•
•
•
•
|
Publication |
First Author: |
Soundararajan R |
Year: |
2016 |
Journal: |
Aging (Albany NY) |
Title: |
Global gene profiling of aging lungs in Atp8b1 mutant mice. |
Volume: |
8 |
Issue: |
9 |
Pages: |
2232-2252 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ueha S |
Year: |
2007 |
Journal: |
J Leukoc Biol |
Title: |
Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. |
Volume: |
81 |
Issue: |
1 |
Pages: |
176-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tu GW |
Year: |
2019 |
Journal: |
J Cell Mol Med |
Title: |
CXCL16/CXCR6 is involved in LPS-induced acute lung injury via P38 signalling. |
Volume: |
23 |
Issue: |
8 |
Pages: |
5380-5389 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cassidy MF |
Year: |
2022 |
Journal: |
Mol Immunol |
Title: |
Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3. |
Volume: |
152 |
|
Pages: |
140-152 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sandor AM |
Year: |
2019 |
Journal: |
Front Immunol |
Title: |
CD11c+ Cells Are Gatekeepers for Lymphocyte Trafficking to Infiltrated Islets During Type 1 Diabetes. |
Volume: |
10 |
|
Pages: |
99 |
|
•
•
•
•
•
|
Publication |
First Author: |
Su X |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
γδ T cells recruitment and local proliferation in brain parenchyma benefit anti-neuroinflammation after cerebral microbleeds. |
Volume: |
14 |
|
Pages: |
1139601 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shimaoka T |
Year: |
2000 |
Journal: |
J Biol Chem |
Title: |
Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. |
Volume: |
275 |
Issue: |
52 |
Pages: |
40663-6 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
246
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
119
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
233
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
246
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Abel S |
Year: |
2004 |
Journal: |
J Immunol |
Title: |
The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. |
Volume: |
172 |
Issue: |
10 |
Pages: |
6362-72 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Chemokines are proteins that have important physiological and pathophysiological roles in a wide range of acute and chronic inflammatory processes []. Chemokines exert their biological effects by binding to cell surface receptors. Their sequences are similar and are characterised by a 4-cysteine motif: the family can be divided according to whether the first 2Cys residues are adjacent (the C-C family), separated by an intervening residue (the C-x-C family), have only one of the first two Cys residues (C chemokines), or contain both cysteines, separated by threeintervening residues (C-x3-C chemokines). This entry represents a novel chemokine, chemokine (C-X-C motif) ligand 16 (CXCL16), has been identified that is a member of the C-X-C family [, ], it is also called SR-PSOX. Despite possessing the CXC motif, however, it is distantly related to the other family members and has greatest sequence similarity to members of the C-C family []. CXCL16 also differs in structure from the other family members (all of which are secreted proteins) and contains a TM domain linked to the chemokine domain by a heavily glycosylated mucin stalk. This structure is similar to that of the CX3C chemokine ligand 1 (CX3C chemokine fractalkine), the only other known chemokine with a TM domain. CXCL16 has been found to be expressed in the spleen, lymph nodes, Peyer's patches and thymus. In non-lymphoid tissues, CXCL16 is found in the lung, small intestine, kidney, heart and liver []. The chemokine appears to be expressed as a membrane-bound cell surface ligand on antigen presenting cells (APCs), such as B cells and macrophages []. CXCL16 can also be shed from the cell surface in an active, soluble form [, ]. These two forms may have different functions. Expression of CXCL16 is upregulated by exposure to inflammatory stimuli.CXCL16 induces a strong chemotactic response. It induces calcium mobilisation and binds to chemokine receptor CXCR6 and HIV-coreceptor Bonzo [, ]. It also acts as a scavenger receptor on macrophages, which specifically binds to OxLDL (oxidized low density lipoprotein), suggesting that it may be involved in pathophysiology such as atherogenesis []. Expression of CXCL16 is induced by the inflammatory cytokines IFN-gamma and TNF-alpha []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Chalabi-Dchar M |
Year: |
2015 |
Journal: |
Gastroenterology |
Title: |
Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16. |
Volume: |
148 |
Issue: |
7 |
Pages: |
1452-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Horuk R |
Year: |
2001 |
Journal: |
Cytokine Growth Factor Rev |
Title: |
Chemokine receptors. |
Volume: |
12 |
Issue: |
4 |
Pages: |
313-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ma Q |
Year: |
1998 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. |
Volume: |
95 |
Issue: |
16 |
Pages: |
9448-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Charbonnier AS |
Year: |
1999 |
Journal: |
J Exp Med |
Title: |
Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. |
Volume: |
190 |
Issue: |
12 |
Pages: |
1755-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sallusto F |
Year: |
1998 |
Journal: |
J Exp Med |
Title: |
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. |
Volume: |
187 |
Issue: |
6 |
Pages: |
875-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Strieter RM |
Year: |
1995 |
Journal: |
J Biol Chem |
Title: |
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. |
Volume: |
270 |
Issue: |
45 |
Pages: |
27348-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zlotnik A |
Year: |
2000 |
Journal: |
Immunity |
Title: |
Chemokines: a new classification system and their role in immunity. |
Volume: |
12 |
Issue: |
2 |
Pages: |
121-7 |
|
•
•
•
•
•
|